Searching for Solutions

The U.S. administration has continuously chipped away at public health interventions addressing substance use disorders and the opioid crisis, including vital harm-reduction activities.

Unhealthy alcohol use is highly prevalent in the United States, with almost half of all regular consumers reporting binge drinking.

Compared with varenicline alone, combination therapy was associated with statistically significantly higher abstinence rates at the longest follow-up.

The National Council Medical Director Institute (MDI) has released the first-ever standardized performance benchmarks for initiation and continuation of long-acting medications for psychotic disorders, bipolar disorder, opioid use disorder and alcohol use disorder. Past President Jerry McKee represented AAPP on the expert panel while Past President Ray Love contributed as a representative of NASMHPD. Download the MDI report to learn how to implement these benchmarks in your practice.

The helpline is a free, confidential service providing caregiver-led support, tools and strategies, trusted guidance, and connection at every stage of the caregiving journey.

No summary available

No summary available

For the fourth time, remote prescribing of controlled substances will be allowed without permanent policy. The Trump administration appears poised to extend a temporary, Covid-era rule allowing health providers to prescribe certain controlled substances, like ADHD medications and treatments for opioid addiction, via telemedicine.

This study's findings have implications for disease classification, precision medicine and clinical practice.

This study examined longer-term health outcomes associated with CM treatment for StUD.

Despite widespread attention to the opioid overdose crisis, alcohol use continues to represent a pressing and under-recognized public health challenge.

GLP-1RAs, traditionally prescribed for glycemic control in T2DM and weight management in obesity, are emerging as promising therapies for ASUDs.

Targeted efforts to enhance patient knowledge of MAUD could be a promising strategy for increasing medication uptake.

In this multicenter randomized clinical trial, RI had higher retention than SI overall and in patients who tested positive for fentanyl through extended-release buprenorphine injection 2.

Despite widespread health misinformation, 83% of patients still trust their doctors most for medical advice, up from 81% last year.

Clinicians should consider systematically assessing physical function in middle-aged patients who have polypharmacy, to capture physical decline earlier in the lifespan.

An umbrella review of nine systematic reviews published in BMJ shows no link between maternal acetaminophen (Tylenol) use during pregnancy and autism or attention deficit hyperactivity disorder (ADHD) in children.

To address provider cash-flow issues resulting from the expiration of Medicare telehealth flexibilities on Oct. 1, CMS announced Nov. 6 that they will return affected claims submitted on or before Nov. 10 and enable providers to resubmit them with expanded coding that clearly demonstrates eligibility under current law.

No summary available

AAPP members Andrew Hean, PharmD, APh, BCPS, BCPP, and Winter Roth, PharmD, BCPP, authored this article in the Journal of the American College of Clinical Pharmacy.